Medical Affairs Reputations: Cancer Pain (EU5) 2017

NEW YORK, Nov. 9, 2017 /PRNewswire/ -- The medical oncologists we surveyed say that medical affairs teams for cancer pain drugs turned in a disappointing performance in the past 6 months. Their ratings on individual services barely crept above neutral, and they're failing to deliver the...